Lee Financial’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Lee Financial’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-775	Closed	-$46K	–	468
2018 Q3	$46K	Hold	775	–	–	0.01%	196
2018 Q2	$42K	Hold	775	–	–	0.01%	273
2018 Q1	$38K	Hold	775	–	–	0.01%	277
2017 Q4	$37K	Hold	775	–	–	0.01%	207
2017 Q3	$39K	Hold	775	–	–	0.01%	198
2017 Q2	$35K	Hold	775	–	–	0.01%	212
2017 Q1	$33K	Hold	775	–	–	0.01%	193
2016 Q4	$30K	Buy	+775	New	+$31.3K	0.02%	204

Other funds holding PBE

ACM

Arlington Capital Management Arlington Heights, Illinois $177M AUM 44.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Lee Financial's PBE Position: Q4 2018 in Review

Lee Financial sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2018, closing a stake of 775 shares — an estimated $46K sold.

Lee Financial first reported a position in PBE in Q4 2016 and held it in 8 quarters. The position peaked at $46K in Q3 2018. 71 funds tracked by Wall St. Rank hold PBE as of Q4 2018.

Lee Financial reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2018 after selling out during the quarter.
Lee Financial sold 775 Invesco Biotechnology & Genome ETF shares in Q4 2018, an estimated $46K.
Lee Financial first reported a position in Invesco Biotechnology & Genome ETF in Q4 2016 and held it in 8 quarters.
Lee Financial's Invesco Biotechnology & Genome ETF position peaked at $46K in Q3 2018.
71 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2018.

Based on Lee Financial's 13F filing for Q4 2018, filed 11 Feb 2019.